scholarly journals Smoking habits and teachable moment among hospitalized patients admitted to the internal medicine department

2012 ◽  
Vol 2 (1) ◽  
pp. 6 ◽  
Author(s):  
Dennis Bösch

Hospitalization seems a favorable setting to quit smoking. The purpose of this study was to determine the smoking habits and teachable moments among hospitalized patients admitted to the internal medicine department. A prospective study involving 253 patients admitted to an academic teaching hospital was conducted. The rate of current smokers ranged from 75% in the group of 30 to 39-year-old male patients to 0% in female patients 80 years and older; mean prevalence 34%. Although males had a higher prevalence of smoking in the younger population, the number of current smokers between the genders nearly converged in patients greater or equal to 50 years of age. Among the internal subspecialties, it was highest in patients admitted for pulmonary disease. The number of patients that quit smoking before discharge was similar between both genders, but significantly different among the age-groups and subspecialties. The fraction of quitters was greater in patients 50 years and older, compared to patients less than 50 years (35% <em>vs.</em> 11%, respectively), and in patients admitted for pulmonary disease, compared to all other patients (33% <em>vs.</em> 12%, respectively). In summary, smoking habits among inpatients are very heterogenous, depending on age, gender, and medical reason for admission. Highest prevalences are found in young, male patients, as well as patients admitted for pulmonary disease. On the other hand, the rate of quitters is significantly greater in patients 50 years and older, and patients admitted for pulmonary disease. Besides targeting our efforts at those who are susceptible to the effects, within the scope of secondary and tertiary prevention of many chronic pulmonary and cardiac diseases, it might be favorable and most efficient to focus on the young, middle-aged patients in tailoring specific support, especially in respiratory medicine.

2020 ◽  
Vol 79 ◽  
pp. 142-144
Author(s):  
Vassilios A. Sevastianos ◽  
Charalampia V. Geladari ◽  
Theodoros A. Voulgaris ◽  
Anna I. Georgantoni ◽  
Emmanuel A. Andreadis

2011 ◽  
Vol 22 ◽  
pp. S56
Author(s):  
Nikolaos Magkas ◽  
Vasiliki Mylona ◽  
George Karlis ◽  
Eleni Armeni ◽  
Konstantinos Paraskevopoulos ◽  
...  

2017 ◽  
Vol 6 (2) ◽  
pp. 107-111
Author(s):  
Rene Suzan Claude Sarker ◽  
Md Raziur Rahman ◽  
Samira Rahat Afroze ◽  
Muhammad Abdur Rahim ◽  
Khwaja Nazim Uddin

Background: Cancer prevalence in diabetic patients in Bangladesh seems to be increasing as case detection of both diseases are far more than before. Till date no statistical data of diabetic patients with malignancy is available in Bangladesh. Treating both diabetes and malignancy in the same patient is challenging and sometimes requires multidisciplinary support. For such cases BIRDEM General Hospital offers supportive facilities including intensive care, chemotherapy, surgical intervention and oncology day care.Methods: This cross-sectional, observational study was carried out from January 2012 to June 2016 which included cancer patients irrespective of their diabetic status admitted in Internal Medicine Department of BIRDEM General Hospital. With prior informed consent of the patients, data were collected and statistical analysis was done using professional SPSS version 17.0 windows based program.Results: Total number of cancer patients was 114, whose diagnoses were confirmed by histopathological evidence (biopsy/FNAC), radiology reports and cancer markers, as appropriate. Among them 64 (56.1%) were male and 50 (43.9%) were female patients. Age of most of the patients was between 41-60 years (65, 57%). Mean age was 55.16 years in diabetic group and 44.47 years in non-diabetic group. Glycemic status revealed that most of the patients were diabetic (80, 70.2%). Among other co-morbid conditions, hypertension and ischemic heart disease were predominant (17 and 9 cases respectively). Prevalence of more than one comorbidites were marked in the diabetic group (33 cases, p value >0.001). Twenty one categories of malignancies were diagnosed during this study period. Majority of cases were lymphoma (21,18.4%), carcinoma breast (17,14.9%), carcinoma uterus and/or cervix (13,11.4%) and leukaemia (10,8.8%). Common clinical features included palpable lump (21,18.4%), lymphadenopathy (16,14%), anaemia (9,7.9%) and pain (8,7%). The number of patients presenting with multiple signs/symptoms were also significant (32,28.1%). Most patients were treated with chemotherapy (54,47.4%). Many cases warranted a combined approach (46,40.4%). Treatment response showed good response in 57(50%) cases. In 16 patients (14%) condition deteriorated and death occurred in 8 cases (7%). Even after repeated and empathic counseling we lost follow up of 15 cases (13.2%).Conclusion: The scenario becomes complicated when a diabetic patient develops malignancy and vice versa. Complications can arise from either spectrum of the diseases. Managing such cases are often challenging and require multi-disciplinary support. Management outcome of these cases so far in Internal Medicine Department, BIRDEM General Hospital shows a promising future.Birdem Med J 2016; 6(2): 107-111


2005 ◽  
Vol 27 (4) ◽  
pp. 351-352 ◽  
Author(s):  
Ana Mirco ◽  
Luís Campos ◽  
Fátima Falcão ◽  
João Silva Nunes ◽  
Ana Aleixo

Sign in / Sign up

Export Citation Format

Share Document